Projected Cost-Effectiveness of Ezetimibe/Simvastatin Compared with Doubling the Statin Dose in the United Kingdom: Findings from the INFORCE Study

Author： Reckless John   Davies Glenn   Tunceli Kaan   Hu X. Henry   Brudi Philippe  

Publisher： Blackwell Publishing

ISSN： 1098-3015

Source： Value in Health, Vol.13, Iss.6, 2010-09, pp. : 726-734

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ezetimibe/simvastatin: Liver failure after conversion from simvastatin to ezetimibe/simvastatin in an elderly patient: case report

By  

Reactions Weekly, Vol. 1, Iss. 1223, 2008-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Ezetimibe–Simvastatin, a pharmacodynamic interaction?

By Lozano Roberto   Marin Reyes   Santacruz M-Jesus   Freire Isabel  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 3, 2013-02 ,pp. : 359-360

Informa Healthcare

Access to resources Recommend Favorite

Cost Effectiveness of Ezetimibe in Patients with Cardiovascular Disease and Statin Intolerance or Contraindications: A Markov Model

By Ara Roberta  

American Journal of Cardiovascular Drugs, Vol. 8, Iss. 6, 2008-01 ,pp. : 419-427

Adis International

Access to resources Recommend Favorite

Cost-effectiveness of Erlotinib versus Docetaxel for Second-line Treatment of Advanced Non-small-cell Lung Cancer in the United Kingdom

By Lewis G   Peake M   Aultman R   Gyldmark M   Morlotti L   Creeden J   de la Orden M  

The Journal of International Medical Research, Vol. 38, Iss. 1, 2010-01 ,pp. : 9-21

Field House Publishing

Access to resources Recommend Favorite

Ezetimibe cost-effective option in statin intolerance

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 571, 2009-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite